ERIS LIFESCIENCES LTD.
|Source Date||Board Meeting Date||Details|
|24-Jun-2019||03-Jul-2019||Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/07/2019 ,inter alia, to consider and approve We hereby inform that the Board of Directors will consider a proposal of buyback of the fully paid-up equity shares of the Company of face value of Re. 1/- each at its meeting scheduled to be held on 3rd July, 2019. The outcome of the Board Meeting will be disseminated to stock exchanges after conclusion of the Board Meeting on 3rd July, 2019. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Policy on 'Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company'', the Trading Window of the Company shall remain closed from 25th June, 2019 to 5th July, 2019 (Both Days Inclusive).|
|25-Oct-2018||03-Nov-2018||ERIS LIFESCIENCES LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2018 ,inter alia, to consider and approve NOTICE IS HEREBY given that a Meeting of the Board of Directors of Eris Lifesciences Limited ('the Company') is scheduled to be held on Saturday, 3rd November, 2018 to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter / half year ended 30th September, 2018. Further, pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on 'Code of conduct to regulate, monitor and report trading by Insiders' of the Company, the Trading Window for dealing in shares of the Company will remain closed from 26th October, 2018 to 5th November, 2018 (both days inclusive) for the purpose of this Board Meeting.|